Stay updated on Venetoclax + Azacitidine in MDS Clinical Trial
Sign up to get notified when there's something new on the Venetoclax + Azacitidine in MDS Clinical Trial page.

Latest updates to the Venetoclax + Azacitidine in MDS Clinical Trial page
- Check7 days agoChange DetectedNew Terminated status posted on 2026-02-12 with related Study Status/Recruitment Status updates, including a <75% participation note. The prior status 'Active, not recruiting' was removed on 2025-12-24.SummaryDifference0.7%

- Check14 days agoChange DetectedRevision entry v3.4.2 was added to the record history; the prior site-wide funding notice (and revision v3.4.1) was removed.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a government funding lapse notice stating information may not be up to date and that some transactions may not be processed, and updated the page revision to v3.4.1.SummaryDifference0.7%

- Check28 days agoChange DetectedThe page now shows a glossary toggle, color-coded change highlights (green for additions, red for deletions), a new revision label (v3.4.0), and removal of the 'No FEAR Act Data' text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) is added to the Record History, while the previous revision (v3.3.3) is removed.SummaryDifference0.1%

- Check57 days agoChange DetectedNew version 14 with Study Status was added on 2025-12-24. The entry from 2025-12-17 was removed.SummaryDifference0.4%

Stay in the know with updates to Venetoclax + Azacitidine in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax + Azacitidine in MDS Clinical Trial page.